vs
Side-by-side financial comparison of HA Sustainable Infrastructure Capital, Inc. (HASI) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $114.8M, roughly 1.1× HA Sustainable Infrastructure Capital, Inc.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -46.8%, a 50.1% gap on every dollar of revenue. On growth, HA Sustainable Infrastructure Capital, Inc. posted the faster year-over-year revenue change (13.3% vs 4.7%). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 4.2%).
HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
HASI vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.8M | $123.8M |
| Net Profit | $-53.8M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | -57.4% | 4.3% |
| Net Margin | -46.8% | 3.3% |
| Revenue YoY | 13.3% | 4.7% |
| Net Profit YoY | -176.7% | 1379.4% |
| EPS (diluted) | $-0.38 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.8M | $123.8M | ||
| Q3 25 | $103.1M | $128.3M | ||
| Q2 25 | $85.7M | $114.8M | ||
| Q1 25 | $96.9M | $113.2M | ||
| Q4 24 | $101.3M | $118.2M | ||
| Q3 24 | $82.0M | $114.6M | ||
| Q2 24 | $94.5M | $110.6M | ||
| Q1 24 | $105.8M | $111.0M |
| Q4 25 | $-53.8M | $4.1M | ||
| Q3 25 | $83.3M | $5.3M | ||
| Q2 25 | $98.4M | $5.3M | ||
| Q1 25 | $56.6M | $4.7M | ||
| Q4 24 | $70.1M | $-321.0K | ||
| Q3 24 | $-19.6M | $4.3M | ||
| Q2 24 | $26.5M | $1.3M | ||
| Q1 24 | $123.0M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | -57.4% | 4.3% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | 84.7% | 5.4% | ||
| Q4 24 | 90.9% | 3.8% | ||
| Q3 24 | -32.1% | 4.6% | ||
| Q2 24 | 39.5% | 5.1% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | -46.8% | 3.3% | ||
| Q3 25 | 80.8% | 4.2% | ||
| Q2 25 | 114.9% | 4.6% | ||
| Q1 25 | 58.4% | 4.2% | ||
| Q4 24 | 69.2% | -0.3% | ||
| Q3 24 | -23.9% | 3.8% | ||
| Q2 24 | 28.1% | 1.2% | ||
| Q1 24 | 116.3% | 2.1% |
| Q4 25 | $-0.38 | $0.23 | ||
| Q3 25 | $0.61 | $0.30 | ||
| Q2 25 | $0.74 | $0.28 | ||
| Q1 25 | $0.44 | $0.25 | ||
| Q4 24 | $0.58 | $-0.02 | ||
| Q3 24 | $-0.17 | $0.23 | ||
| Q2 24 | $0.23 | $0.07 | ||
| Q1 24 | $0.98 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $110.2M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $161.6M |
| Total Assets | $8.2B | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $110.2M | $93.9M | ||
| Q3 25 | $301.8M | $95.6M | ||
| Q2 25 | $86.5M | $81.3M | ||
| Q1 25 | $67.4M | $86.5M | ||
| Q4 24 | $129.8M | $84.7M | ||
| Q3 24 | $44.1M | $78.7M | ||
| Q2 24 | $145.7M | $68.7M | ||
| Q1 24 | $61.4M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $2.7B | $161.6M | ||
| Q3 25 | $2.7B | $166.7M | ||
| Q2 25 | $2.6B | $163.7M | ||
| Q1 25 | $2.5B | $167.1M | ||
| Q4 24 | $2.4B | $161.0M | ||
| Q3 24 | $2.3B | $162.6M | ||
| Q2 24 | $2.3B | $156.4M | ||
| Q1 24 | $2.3B | $159.7M |
| Q4 25 | $8.2B | $261.1M | ||
| Q3 25 | $8.2B | $264.8M | ||
| Q2 25 | $7.6B | $254.9M | ||
| Q1 25 | $7.5B | $252.7M | ||
| Q4 24 | $7.1B | $240.9M | ||
| Q3 24 | $6.7B | $245.3M | ||
| Q2 24 | $6.7B | $235.8M | ||
| Q1 24 | $6.7B | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.3M | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $9.9M | ||
| Q3 25 | $-121.8M | $18.5M | ||
| Q2 25 | $79.6M | $4.3M | ||
| Q1 25 | $-37.1M | $2.6M | ||
| Q4 24 | $5.9M | $12.2M | ||
| Q3 24 | $21.9M | $9.6M | ||
| Q2 24 | $-24.8M | $1.3M | ||
| Q1 24 | $20.9M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | -1.46× | 3.46× | ||
| Q2 25 | 0.81× | 0.81× | ||
| Q1 25 | -0.66× | 0.55× | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | -0.94× | 0.97× | ||
| Q1 24 | 0.17× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HASI
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
